Editors

Editor-in-Chief:
Ruben A. Mesa, MD (Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA)

Editorial Board:

Frederick R. Appelbaum, MD (Fred Hutchinson Cancer Research Center, Seattle, Washington, USA)
John C. Byrd, MD (Ohio State University, Columbus, Ohio, USA)
Myron S. Czuczman, MD (Citius Pharmaceuticals, Inc, Cranford, New Jersey, USA)
David Gomez-Almaguer, MD (Hospital Universitario UANL, Monterrey, Mexico)
Nelson Hamerschlack, MD, PhD (Hospital Israelita Albert Einstein, Sao Paulo, Brazil)
Jean-Luc Harousseau, MD (University Hospital Hotel Dieu, Nantes, France)
Claire Harrison, MD, FRCP, FRCPath (Guy's and St. Thomas' NHS Foundation Trust, London, England, United Kingdom)
Armand Keating, FRCPC, MD (Princess Margaret Hospital, Ontario Cancer Institute, Toronto, Ontario, Canada)
Alan F. List, MD (H. Lee Moffitt Cancer Center, Tampa, Florida, USA)
Jesús San Miguel, MD, PhD (Hospital Universitario de Salamanca, Salamanca, Spain)
Emili Montserrat, MD (University of Barcelona, Barcelona, Spain)
Carolina Pavlovsky, MD (Foundation to Fight Leukemia, Buenos Aires, Argentina)
Ching-Hon Pui, MD (St. Jude Children’s Research Hospital, Memphis, Tennessee, USA)
John F. Seymour, MD (Peter MacCallum Cancer Centre, Melbourne, Australia)
Koen Van Besien, MD (University of Chicago, Chicago, Illinois, USA)

2022 Sections and Section Editors:

Acute  Lymphocytic Leukemias
Firas El Chaer, MD (University of Virginia Health System, Charlottesville, Virginia, USA)
Michael Keng, MD (University of Virginia Health System, Charlottesville, Virginia, USA)

Acute Myeloid Leukemias
Uma Borate, MBBS (Oregon Health and Sciences University, Portland, Oregon, USA)

B-cell NHL, T-cell NHL, and Hodgkin Lymphoma
Jennifer Amengual, MD (Columbia University, New York, New York, USA)
 

CART and Immunotherapy
Patrick Hanley, PhD (Children's National Health System, Washington, DC, USA)
Yong Gu Lee, PhD (Hanyang University, South Korea)
 

Chronic Lymphocytic Leukemias
Nitin Jain, MD, MSPH (University of Texas MD Anderson Cancer Center, Houston, Texas, USA)

Chronic Myeloid Leukemias
Vivian Oehler, MD (Fred Hutchinson Cancer Research Center, Seattle, WA, USA)

Health Economics
Nandita Khera, MD, MPH (Mayo Clinic, Phoenix, Arizona, USA)

Multiple Myeloma 
Prashant Kapoor, MD (Mayo Clinic, Rochester, Minnesota, USA)

Myeloproliferative Neoplasms
Prithvi Bose, MD (The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)

T-Cell and Other Lymphoproliferative Malignancies
Jasmine Zain, MD (City of Hope Medical Center, Duarte, California, USA)

Telomere Biology Disorders
Mrinal Patnaik, MD (Mayo Clinic, Rochester, Minnesota, USA)